Prothena
Wenying Huang has extensive experience in the field of biostatistics. Wenying is currently working as a Senior Director of Biostatistics at Prothena Corporation plc since May 2022. Prior to this, they served as the Director of Biostatistics at MEI Pharma from 2020 to 2022. From 2014 to 2020, Wenying worked as a Biostatistics Consultant. Wenying began their career as a Senior Statistician at Amylin Pharmaceuticals in July 2008 and held this position until May 2014.
From 2003 to 2008, Wenying Huang attended Colorado State University. However, no specific degree or field of study information is provided.
This person is not in any teams
This person is not in any offices
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating neurological disorders.